Crossject (ALCJ) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.893x

Based on the latest financial reports, Crossject (ALCJ) has a cash flow conversion efficiency ratio of 2.893x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.23 Million ≈ $-3.78 Million USD) by net assets (€-1.12 Million ≈ $-1.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Crossject - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Crossject's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Crossject carry for a breakdown of total debt and financial obligations.

Crossject Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Crossject ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Merck Tbk JK:MERK	0.165x
Eusu Holdings KO:000700	0.031x
Sedana Medical AB ST:SEDANA	-0.006x
Se Gyung Hi Tech Co.Ltd KQ:148150	0.105x
Yuhwa Sec KO:003460	0.183x
Cube Entertainment Inc KQ:182360	-0.108x
Nonthavej Hospital Public Company Limited BK:NTV	0.041x
Macrogen Inc KQ:038290	0.042x

Annual Cash Flow Conversion Efficiency for Crossject (2012–2024)

The table below shows the annual cash flow conversion efficiency of Crossject from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see ALCJ company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-2.67 Million ≈ $-3.13 Million	€-7.96 Million ≈ $-9.30 Million	2.977x	+152.94%
2023-12-31	€-5.27 Million ≈ $-6.16 Million	€-6.20 Million ≈ $-7.25 Million	1.177x	+162.23%
2022-12-31	€2.69 Million ≈ $3.14 Million	€-5.08 Million ≈ $-5.94 Million	-1.891x	-270.39%
2021-12-31	€-5.48 Million ≈ $-6.41 Million	€-6.08 Million ≈ $-7.11 Million	1.110x	-77.03%
2020-12-31	€-1.13 Million ≈ $-1.32 Million	€-5.46 Million ≈ $-6.39 Million	4.833x	+364.36%
2019-12-31	€3.01 Million ≈ $3.52 Million	€-5.51 Million ≈ $-6.44 Million	-1.828x	+62.27%
2018-12-31	€1.65 Million ≈ $1.93 Million	€-8.02 Million ≈ $-9.37 Million	-4.845x	-492.85%
2017-12-31	€6.09 Million ≈ $7.11 Million	€-4.97 Million ≈ $-5.82 Million	-0.817x	-16.62%
2016-12-31	€6.28 Million ≈ $7.35 Million	€-4.40 Million ≈ $-5.15 Million	-0.701x	-28.56%
2015-12-31	€8.80 Million ≈ $10.29 Million	€-4.80 Million ≈ $-5.61 Million	-0.545x	-149.64%
2014-12-31	€14.48 Million ≈ $16.93 Million	€-3.16 Million ≈ $-3.70 Million	-0.218x	+78.53%
2013-12-31	€947.65K ≈ $1.11 Million	€-964.00K ≈ $-1.13 Million	-1.017x	-440.48%
2012-12-31	€-1.90 Million ≈ $-2.23 Million	€-569.06K ≈ $-665.29K	0.299x	--

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$116.85 Million

€99.95 Million EUR

Market Cap Rank

#18801 Global

#283 in France

Share Price

€1.90

Change (1 day)

-0.63%

52-Week Range

€1.02 - €2.69

All Time High

€10.40